Absci Corporation Share Price
NASDAQ: ABSIAbsci Corporation Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Absci Corporation Share Price Chart
Absci Corporation Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-0.84 | Revenue (TTM) $2.80M | Return On Equity (TTM) -60.80% |
Profit Margin -4113.68% | Debt to Equity 0.12 | Quarterly Earnings Growth YoY -4.77% |
Absci Corporation Quarterly Profit & Loss
All figures in USD
Absci Corporation Annual Profit & Loss
All figures in USD
About Absci Corporation
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corporation Historical Returns
| Month | Open | Close | Change % |
|---|